You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: August 14, 2024

METHIMAZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Methimazole patents expire, and when can generic versions of Methimazole launch?

Methimazole is a drug marketed by Bionpharma, Chartwell Rx, Discovery Therap, Heritage Pharma, Macleods Pharms Ltd, Mylan, Qingdao Baheal Pharm, Rising, and Sun Pharm Inds Inc. and is included in nine NDAs.

The generic ingredient in METHIMAZOLE is methimazole. There are three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methimazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Methimazole

A generic version of METHIMAZOLE was approved as methimazole by MYLAN on March 29th, 2000.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for METHIMAZOLE?
  • What are the global sales for METHIMAZOLE?
  • What is Average Wholesale Price for METHIMAZOLE?
Drug patent expirations by year for METHIMAZOLE
Drug Prices for METHIMAZOLE

See drug prices for METHIMAZOLE

Drug Sales Revenue Trends for METHIMAZOLE

See drug sales revenues for METHIMAZOLE

Recent Clinical Trials for METHIMAZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Case Comprehensive Cancer CenterPhase 2
The First Affiliated Hospital of Xiamen UniversityPhase 2/Phase 3
Shunde Hospital, Southern Medical UniversityEarly Phase 1

See all METHIMAZOLE clinical trials

Pharmacology for METHIMAZOLE
Medical Subject Heading (MeSH) Categories for METHIMAZOLE

US Patents and Regulatory Information for METHIMAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma METHIMAZOLE methimazole TABLET;ORAL 218149-001 Sep 25, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds Inc METHIMAZOLE methimazole TABLET;ORAL 040870-001 Sep 25, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage Pharma METHIMAZOLE methimazole TABLET;ORAL 040734-002 Dec 14, 2007 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx METHIMAZOLE methimazole TABLET;ORAL 040411-002 Mar 27, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan METHIMAZOLE methimazole TABLET;ORAL 040350-003 Jun 7, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.